2025 · 2nd Quarter (Apr 1 - June 30)

IONIS PHARMACEUTICALS, INC.

Filed by IONIS PHARMACEUTICALS, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 16, 2025
Income: Not reported
Expenses: $90,000.00
Registrant: IONIS PHARMACEUTICALS, INC.
Client: IONIS PHARMACEUTICALS, INC.
Filing UUID: 6838f339-50fe-40ad-b320-a76ee8873e8f
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act.

Literal federal measure citations: H.R.1672, H.R.1262, S.932, H.R.946, S.1862, H.R.1492, S.832

MMM · Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act. Issues related to the Medicaid rebate.

Literal federal measure citations: H.R.1672, H.R.946, S.1862, H.R.1492, S.832

TAX · Taxation/Internal Revenue Code

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Literal federal measure citations: H.R.1414

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.